세계의 말용 의약품과 보충제 시장 규모 : 유형별, 유통 채널별, 지역 범위별 및 예측

Equine Pharmaceuticals And Supplements Market Size And Forecast

Equine Pharmaceuticals and Supplements Market size was valued at USD 1085.48 Million in 2024 and is projected to reach USD 1439.34 Million by 2031, at a CAGR of 3.59% from 2024 to 2031. The global equine pharmaceuticals and supplements market has witnessed strong growth owing to the increasing awareness about equine pharmaceuticals and supplements products and increasing demand for herbal digestive, feed, and energy supplements for horses. The Global Equine Pharmaceuticals and Supplements Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Equine Pharmaceuticals and Supplements Market Definition

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to treat disease or improve nutrition. These medicines and dietary supplements include vitamins, proteins, electrolytes and energy supplements. These medical devices are primarily used on donkeys, horses and zebras to heal injuries and provide these animals with energy to keep them healthy and strong.

Equine pharmaceuticals and supplements are medicines or supplements explicitly used to improve nutrition and cure disease. These medicines and dietary supplements contain proteins, vitamins, energy supplements and electrolytes. Equine medication and supplements give horses, donkeys and zebras the energy to heal injuries and stay strong and healthy. Governments and many animal health agencies have raised concerns among several horse industry horse breeders and trainers about the need for good, healthy nutrition and nutritional supplements for the growth and health of horses. In addition, it provides information and raises awareness of the need to prevent various diseases and treat some.

Also, veterinary nutritional supplements (nutraceuticals) are oral products that contain one or more dietary ingredients intended to supplement the diet. These ingredients include vitamins, minerals, herbs or other botanicals, amino acids (the building blocks of proteins), and substances such as enzymes, organ tissue, glands, metabolites, extracts, or concentrates. Supplements are available in many formulations, including pellets, granules, powders, pastes, liquids, injections (intravenous or intramuscular), and pills.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Equine Pharmaceuticals and Supplements Market Overview

The global equine pharmaceuticals and supplements market is driven by increasing awareness of equine pharmaceuticals and supplements. With horse breeders and trainers choosing organic products, demand for herbal digestives, feeds and energy supplements for horses is increasing. It is designed to drive the growth of the pharmaceutical and supplements market during the forecast period.

Moreover, increasing awareness of equine medicines and supplements, increasing demand for herbal feed, and digestive and energy supplements as horse breeders decide to go organic are driving demand for the product. Further, the horseracing and equestrian sports industries are driving the need for equine medicines, as horses' health is essential to the growth of these industries. Healthy horses in specific disciplines give impetus to the betting and gambling industry associated with horse racing. Therefore, most horse trainers and breeders use superior medicines to limit and cure ailments to keep horses in good shape for racing. The horse racing and equestrian sports industry, which relies heavily on horse health, drives demand for equine medicines. As a result, most horse trainers and breeders use high-quality pharmaceuticals to prevent disease and cure disorders to ensure their horses are ready to race.

However, stringent regulations on pharmaceuticals and dietary supplements are significantly hampering the market. The availability of alternative betting and gambling vehicles impacts the horse-related industry in developed countries. It is intended to slow down the growth of the global equine medicines and nutritional supplements market.

The development of horse racing in specific geographic regions is expected to provide expansion opportunities for key players in the global equine medicines and nutritional supplements market. Furthermore, declining horse breeding will lead to declining horse populations and is expected to remain a significant challenge for the market during the forecast period.

Global Equine Pharmaceuticals and Supplements Market Segmentation Analysis

The Global Equine Pharmaceuticals and Supplements Market is segmented based on Type, Distribution Channel, and Geography.

Equine Pharmaceuticals and Supplements Market, By Type

• Pharmaceuticals
• Supplements

Based on Type, the market is bifurcated into Pharmaceuticals and Supplements. The Pharmaceuticals segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing demand for pharmaceuticals to limit illnesses and heal diseases so that the horses are in good shape for the races, thus promulgating segment growth.

Equine Pharmaceuticals and Supplements Market, By Distribution Channel

• Veterinary Hospitals
• Drugstores
• Others

Based on Distribution Channel, the market is bifurcated into Veterinary Hospitals, Drugstores, and Others. The Drugstore's segment is estimated to witness the highest CAGR for the forecast period. The factors attributed to the segment's growth are associated with the increasing owner preference for treating horses in hospitals and improved availability of veterinary supplements. Also, the massive availability of equine pharmaceuticals at drug stores. These medications are used to treat horses, donkeys and zebras.

Equine Pharmaceuticals and Supplements Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• The Asia-Pacific region is anticipated to become the fastest-growing equine pharmaceuticals and supplements market due to the development of horseracing and other horse-related activities in countries such as China, Australia, and New Zealand. With important horse races such as the Dubai World Cup, growth in the Middle East for equine breeding and other related equine sporting and non-sporting sectors is noteworthy and expected to boost the development of the Middle East equine medicines and supplements market.

Key Players

• The "Global Equine Pharmaceuticals and Supplements Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zoetis, Boehringer Ingelheim, Merck & Co, Elanco, Bayer, Ceva Sante Animale, Virbac, Vetoquinol, Affymetrix, Celltrion.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Pharmaceuticals
• 5.3 Supplements

6 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Veterinary Hospitals
• 6.3 Drugstores
• 6.4 Others

7 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East

8 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Zoetis
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Boehringer Ingelheim
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Merck & Co
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Elanco
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Bayer
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Ceva Sante Animale
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Virbac
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Affymetrix
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Celltrion
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Vetoquinol
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research